London, July 13 2009: Following a four-way process, College Hill has been appointed by Imperial Innovations Group plc to manage its financial and corporate communications in order to raise awareness of the Group's rapidly growing reputation as a technology commercialisation and investment leader.
With Imperial College, London as a significant shareholder, Imperial Innovations has unparalleled access to early stage technology and intellectual property in the UK, with a portfolio that includes equity holdings in more than 80 companies across four core areas: Healthcare, Engineering, Energy & Environment and IT & Software.
Imperial Innovations' business model encompasses the identification of ideas, the protection of intellectual property, the development and licensing of technology and the formation, incubation and funding of technology businesses. The strength of this model was highlighted by the recent trade sale of Thiakis Limited, a company leading the field in the development of treatment for obesity and related diabetes and cardio-vascular disease, in which Imperial Innovations had a 23.7% stake, to US-based Wyeth Pharmaceuticals for up to £100 million.
Commenting on the appointment Donna Zurcher, College Hill MD said "Imperial Innovations is a world class company with an exciting portfolio of technologies and a management team with a proven track record. The potential pipeline of life enhancing developments from Imperial Innovations is truly remarkable."
Commenting on the appointment of College Hill, Susan Searle, CEO said: "We selected College Hill from a strong field because we liked the team's questioning and creative approach. We also recognised College Hill's compelling combination of technology and life sciences expertise within their capital markets practice."
For Further Information:
Sue Charles, Managing Partner
UK: +44 (0)20 7457 2020 / +44 (0)7968 726 585
Australia: +61 (0)457 196 222